Site Search
Displaying results 91 - 100 of 345
Resource | Publications,
In November 2017, 117 national delegations adopted the Moscow Declaration to End TB at the first WHO Global Ministerial Conference on Ending TB: A Multisectoral Response. They committed to “supporting the development of a multisectoral accountability framework” to accelerate progress to end TB. They called on WHO to develop the framework, working in close cooperation with relevant partners.
At the 71st World Health Assembly (WHA) in May 2018, Member States welcomed the WHO draft multisectoral accountability framework (hereafter referred to as the MAF-TB). The WHA also requested the Director-General to continue to develop the MAF-TB, in consultation with Member States, and working in close collaboration with partners, as well as to provide technical support for national adaptation and use of the MAF-TB.
Resource | Publications,
Recognizing that the promotion and protection of the human rights of people affected by tuberculosis is a legal, ethical and moral imperative, as well as of crucial importance for the effectiveness of the response to the epidemic and the relief of suffering among affected individuals and communitie.
Resource | Publications,
The goal of the Global Plan is to provide a costed blueprint for actions that countries should take to fulfil the targets and commitments in the Political Declaration of the UNHLM on TB and to get on track to end TB as outlined in the WHO’s End TB Strategy and the SDGs.
Resource | Publications,
Tuberculosis (TB) is curable but it still kills more people globally than any other single infectious disease. This is mainly due to challenges in accessing quality, affordable and equitable TB services and care. Millions of people affected by TB endure its hardships and manage to survive despite these barriers, which are driven by and heightened by TB stigma. Put simply, to end TB, we must end TB stigma.
Resource | Publications,
TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005. The report—Tuberculosis Research Funding Trends, 2005–2018—is a critical accountability tool and serves as a barometer of progress in raising support for the scientific innovation needed to eliminate TB.
Resource | Fact Sheets,
Tuberculosis (TB) is the top infectious killer worldwide, claiming around 4400 lives a day. TB also remains the leading cause of death among people living with HIV, causing one in three AIDS-related deaths. In 2017, 1.6 million people died from TB, including around 300,000 people living with HIV. However, TB is also preventable and curable.
The latest estimates from the World Health Organization (WHO) show that progress has been made towards the target. Global TB deaths among people living with HIV have fallen by 42% since 2010, from 520,000 down to 300,000 in 2017. However, the estimates also indicate that progress remains uneven and further efforts are needed to address the main challenges, including the need for equity and ensuring that vulnerable groups have access to integrated HIV and TB services.
Resource | Guidelines,
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
Resource | Guidelines,
These guidelines have been developed to provide updated, evidence-informed recommendations on tuberculosis (TB) infection prevention and control (IPC) in the context of the global targets of the Sustainable Development Goals (SDGs) and the World Health Organization (WHO) End TB Strategy. The notion and practice of IPC encompasses a set of broader, practical, evidence-based approaches to preventing the community from being harmed by avoidable infections, preventing health care-associated infections (HAI), implementing laboratory biosafety and reducing the spread of antimicrobial resistance (AMR).
Resource | Publications,
Providing evidence-based guidelines to inform public health service delivery for Member States and other stakeholders is one of the core responsibilities of the World Health Organization (WHO). To support countries in responding to the challenges of TB and drug-resistant TB, the WHO Global TB Programme regularly issues evidence-based guidelines using the international GRADE4 (Grading of Recommendations, Assessment, Development and Evaluation) approach for scientific evidence assessment.